Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins

Kayo Osawa, Katsumi Shigemura, Yukie Nukata, Koichi Kitagawa, Fukashi Yamamichi, Hiroyuki Yoshida, Toshiro Shirakawa, Soichi Arakawa, Masato Fujisawa
Kayo Osawa
aDepartment of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsumi Shigemura
bDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
cDepartment of International Health, Kobe University Graduate School of Health Sciences, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukie Nukata
aDepartment of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichi Kitagawa
dDivision of Translational Research for Biologics, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fukashi Yamamichi
eDepartment of Urology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Yoshida
aDepartment of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
fHyogo Clinical Laboratory Corporation, Himeji, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiro Shirakawa
bDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
dDivision of Translational Research for Biologics, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
gDivision of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soichi Arakawa
hDepartment of Urology, Sanda City Hospital, Sanda, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Fujisawa
bDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.01174-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

In recent years, Neisseria gonorrhoeae strains with decreased susceptibility (DS; MIC, >0.064 mg/liter) or resistance to cefixime (CFM) or ceftriaxone (CRO), have been classed as “superbugs” and have spread worldwide, resulting in gonorrhea treatment failures (1–3). In N. gonorrhoeae, the genetic mechanisms of mosaic alleles of penA encoding penicillin-binding protein 2 (PBP2), including the fragments of the penA gene from commensal Neisseria spp., mutation of ponA encoding PBP1, mutation of porB1 encoding the outer membrane porin, and mtrR mutations with overexpression of the MtrCDE efflux pump, have also been reported (4–8). As determined by N. gonorrhoeae multiantigen sequence typing (NG-MAST), which is a sequence-based epidemiological approach, strains highly resistant to CRO are known as sequence type 4220 (ST4220) and ST1407 with mosaic penA-X and -XXXIV in Japan and Europe (3, 9). A total of 73 N. gonorrhoeae strains were isolated from male urethritis or female cervicitis cases in Hyogo, Japan, in 2012. The strains were confirmed to be a gonococcal species by testing with the HN-20 Rapid system (Nissui, Tokyo, Japan). The MICs of penicillin G (PEN), CFM, and CRO were determined by the agar dilution method based on CLSI standards (10). Of 73 N. gonorrhoeae isolates tested, 36% were PEN I (intermediate), 64% were PEN R (resistant), 62% were CFM DS, 14% were CFM R, 7% were CRO DS, and 0% were CRO R. Mosaic penA was seen in 78%, including the penA-X family (42%) and the penA-XXXIV family (21%). An L421P mutation in ponA was seen in 100% of the isolates with mosaic penA. The porB1 mutations were G101K and A102D (36%), G101K and A102N (30%), G101 and A102D (1%), and G101T and A102D (1%). A deletion of the mtrR promoter region was seen in 63%, and mtrR mutations (A39T, A40D, and G45D) were seen in 40% (A39T, 12%; A40D, 16%; G45D, 12%). Isolates with mosaic penA (97%, P < 0.001), an L421P mutation in ponA (87%, P < 0.001), porB1 mutations (90%, P < 0.001), or a deletion of the mtrR promoter region (87%, P = 0.004) were significantly associated with CFM DS/R (Table 1). Fifty (74%) of 68 CRO S isolates were classified as CFM DS/R, and all 50 isolates had a mosaic mutation. Furthermore, five isolates with DS to CRO that were typed as NG-MAST ST6798 with penA-X or ST14150 with penA-XXXIV-P551S had ponA and porB1 mutations and a deletion of the mtrR promoter region, respectively (Table 2). ST14150 strains were assigned to genogroup G1407 (11). ST6798 strains, similar to ST2958, were CFM and CRO R in Fukuoka, Japan (12). Shimuta et al. had shown that NG-MAST ST1407 isolates showed a CRO MIC of 0.125 mg/liter and included penA-XXXIV-P551S (1). Genogroup G1407 strains were widespread in China and Spain between 2012 and 2014 (7, 13) and isolated in Hyogo, Japan. In conclusion, on the basis of our findings, even though we have no data on the patients' backgrounds, including demographic data, NG-MAST ST6789 and ST14150 strains in genogroup G1407 had penA mosaic alleles and ponA, porB1, and mtrR mutations and DS to CRO (MIC, >0.064 mg/liter), and these factors may lead to DS to cephalosporins in N. gonorrhoeae in Hyogo, Japan.

View this table:
  • View inline
  • View popup
TABLE 1

Distribution of penA, ponA, porB1, and mtrR mutations among N. gonorrhoeae isolates in different antibiotic susceptibility groupsa

View this table:
  • View inline
  • View popup
TABLE 2

Characteristics of N. gonorrhoeae strains with DS to CROa

ACKNOWLEDGMENTS

We thank Miki Fujiwara and Seiko Nasu for offering gonococcal samples.

This work was partially supported by the Research Program on Emerging and Reemerging Infectious Diseases from the Japan Agency for Medical Research and Development, AMED. This work, including the efforts of Kayo Osawa, was funded by Japan Agency for Medical Research and Development (17fk0108314h0103).

  • Copyright © 2017 American Society for Microbiology.

All Rights Reserved .

REFERENCES

  1. 1.↵
    1. Shimuta K,
    2. Unemo M,
    3. Nakayama S,
    4. Morita-Ishihara T,
    5. Dorin M,
    6. Kawahata T,
    7. Ohnishi M
    , Antibiotic-Resistant Gonorrhea Study Group. 2013. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother57:5225–5232. doi:10.1128/AAC.01295-13.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Suay-García B,
    2. Pérez-Gracia MT
    . 16February2017. Drug-resistant Neisseria gonorrhoeae: latest developments. Eur J Clin Microbiol Infect Dis doi:10.1007/s10096-017-2931-x.
    OpenUrlCrossRef
  3. 3.↵
    1. Unemo M
    . 2015. Current and future antimicrobial treatment of gonorrhoea—the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis15:364. doi:10.1186/s12879-015-1029-2.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ameyama S,
    2. Onodera S,
    3. Takahata M,
    4. Minami S,
    5. Maki N,
    6. Endo K,
    7. Goto H,
    8. Suzuki H,
    9. Oishi Y
    . 2002. Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother46:3744–3749. doi:10.1128/AAC.46.12.3744-3749.2002.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Ito M,
    2. Deguchi T,
    3. Mizutani KS,
    4. Yasuda M,
    5. Yokoi S,
    6. Ito S,
    7. Takahashi Y,
    8. Ishihara S,
    9. Kawamura Y,
    10. Ezaki T
    . 2005. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother49:137–143. doi:10.1128/AAC.49.1.137-143.2005.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Unemo M,
    2. Shafer WM
    . 2014. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev27:587–613. doi:10.1128/CMR.00010-14.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Serra-Pladevall J,
    2. Barberá MJ,
    3. Rodriguez S,
    4. Bartolomé-Comas R,
    5. Roig G,
    6. Juvé R,
    7. Andreu A
    . 2016. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins. Eur J Clin Microbiol Infect Dis35:1549–1556. doi:10.1007/s10096-016-2696-7.
    OpenUrlCrossRef
  8. 8.↵
    1. Shigemura K,
    2. Osawa K,
    3. Miura M,
    4. Tanaka K,
    5. Arakawa S,
    6. Shirakawa T,
    7. Fujisawa M
    . 2015. Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. Antimicrob Agents Chemother59:2695–2699. doi:10.1128/AAC.04320-14.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Ohnishi M,
    2. Golparian D,
    3. Shimuta K,
    4. Saika T,
    5. Hoshina S,
    6. Iwasaku K,
    7. Nakayama S,
    8. Kitawaki J,
    9. Unemo M
    . 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother55:3538–3545. doi:10.1128/AAC.00325-11.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
  11. 11.↵
    1. Chisholm SA,
    2. Unemo M,
    3. Quaye N,
    4. Johansson E,
    5. Cole MJ,
    6. Ison CA,
    7. Van de Laar MJ
    . 2013. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill18:20358. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20358.
    OpenUrlPubMed
  12. 12.↵
    1. Tanaka M,
    2. Furuya R,
    3. Irie S,
    4. Kanayama A,
    5. Kobayashi I
    . 2015. High prevalence of azithromycin-resistant Neisseria gonorrhoeae isolates with a multidrug resistance phenotype in Fukuoka, Japan. Sex Transm Dis42:337–341. doi:10.1097/OLQ.0000000000000279.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Chen SC,
    2. Yin YP,
    3. Dai XQ,
    4. Unemo M,
    5. Chen XS
    . 2016. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China. J Antimicrob Chemother71:92–99. doi:10.1093/jac/dkv321.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins
Kayo Osawa, Katsumi Shigemura, Yukie Nukata, Koichi Kitagawa, Fukashi Yamamichi, Hiroyuki Yoshida, Toshiro Shirakawa, Soichi Arakawa, Masato Fujisawa
Antimicrobial Agents and Chemotherapy Jul 2017, 61 (8) e01174-17; DOI: 10.1128/AAC.01174-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
penA, ponA, porB1, and mtrR Mutations and Molecular Epidemiological Typing of Neisseria gonorrhoeae with Decreased Susceptibility to Cephalosporins
Kayo Osawa, Katsumi Shigemura, Yukie Nukata, Koichi Kitagawa, Fukashi Yamamichi, Hiroyuki Yoshida, Toshiro Shirakawa, Soichi Arakawa, Masato Fujisawa
Antimicrobial Agents and Chemotherapy Jul 2017, 61 (8) e01174-17; DOI: 10.1128/AAC.01174-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Bacterial Proteins
Carrier Proteins
cephalosporins
Microfilament Proteins
Neisseria gonorrhoeae
porins
Repressor Proteins
Neisseria gonorrhoeae
decreased susceptibility
NG-MAST
cephalosporins
penA mosaic alleles

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596